Newsfeeds - Spark Newswire

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Oct. 11, 2021: TDOC, CRSP, NTLA, NIU, BLDE, MKFG, VLD, TWOU, GENI, BEAM, SLGC, CDNA, QSI, ACHR

Today, 9:54 AM

Teladoc Health (TDOC) - 211,626 CRISPR Therapeutics (CRSP) - 248,148 Intellia Therapeutics (NTLA) - 37,991 Niu Technologies (NIU) - 159,329 Blade Air Mobility (BLDE)

ACHR

2 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 9:54 AM

AGRX

8 minute read

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

By Shanthi Rexaline

Today, 9:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

ABIO

13 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 5, 2021

By Benzinga Insights

Today, 9:54 AM

1 minute read

Guggenheim Initiates Coverage On Intellia Therapeutics with Buy Rating, Announces Price Target of $170

By vishwanath@benzinga.com

Today, 9:54 AM

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Buy rating and announces Price Target of $170.

NTLA

1 minute read

Analyst Ratings

Where Intellia Therapeutics Stands With Analysts

By Benzinga Insights

Today, 9:54 AM

Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings:

NTLA

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 24, 2021

By Benzinga Insights

Today, 9:54 AM

Upgrades

ACHC

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Thursday, Sept. 23, 2021: NSTG, PRLB, IRDM, NTLA, NTDOY, U, PLTR, TER, CLLS, SMFR, CDXS, NVS

By Michael Horton

Today, 9:54 AM

NanoString Technology (NSTG) - 400 Shares Proto Labs (PRLB) - 28,800 Iridium Communications (IRDM) - 50,400 Intellia Therapeutics (NTLA) - 19,950 Nintendo (NTDOY) - 51,209 Unity Software (U) - 222,511 Palantir

CDXS

1 minute read

Stifel Initiates Coverage On Intellia Therapeutics with Buy Rating, Announces Price Target of $173

By Benzinga Newsdesk

Today, 9:54 AM

Stifel analyst Dae Gon Ha initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Buy rating and announces Price Target of $173.

NTLA

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Wednesday, Sept. 22, 2021: NSTG, PRLB, IRDM, NTDOY, NTLA, SE, TER, NXPI, LC, ETSY, SMFR, CLLS, BMY, CDXS, NVS, NVDA

By Michael Horton

Today, 9:54 AM

NanoString Technologies (NSTG) - 3,951 Shares Proto Labs (PRLB) - 39,453 Iridium Communications (IRDM) - 172,348 Nintendo (NTDOY) - 129,900 Intellia Therapeutics (NTLA) - 66,750 Sea (SE) - 69,679 Teradyne (TER) -

BMY